AASS Back

aminoadipate-semialdehyde synthase

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of AASS
This gene encodes a bifunctional enzyme that catalyzes the first two steps in the mammalian lysine degradation pathway. The N-terminal and the C-terminal portions of this enzyme contain lysine-ketoglutarate reductase and saccharopine dehydrogenase activity, respectively, resulting in the conversion of lysine to alpha-aminoadipic semialdehyde. Mutations in this gene are associated with familial hyperlysinemia. Sequence Note: This RefSeq record was created from transcript and genomic sequence data to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on alignments.

Community Annotation of AASS Add / Edit AASS: Annotations

No community annotations yet for AASS.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

AASS is highly significantly mutated in
(none)
AASS is significantly mutated in
(none)
AASS is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


• Mutation list for AASS